LANXESS worldwide

Corporate Website en | de


  • Australia en

  • China cn | en

  • India en

  • Indonesia en

  • Japan jp

  • Korea kr

  • Malaysia en

  • Pakistan en

  • Philippines en

  • Singapore

  • Thailand en

  • Vietnam en


  • Austria en

  • Belgium nl

  • Czech en

  • France fr

  • Hungary en

  • Italy en

  • Netherlands en

  • Poland en

  • Russia en

  • Serbia en

  • Slovakia en

  • Spain en

  • Turkey en

  • United Arab Emirates en

  • United Kingdom en



LANXESS Canada Contacts

Contact our Sites in Canada


Media Inquiries

Global Press Releases


LANXESS at VIV Europe 2018, Jaarbeurs-Utrecht, The Netherlands, stand AO11, hall 10, June 20 - 22, 2018

Strict biosecurity recommended in the fight against African Swine Fever

Cologne – With African Swine Fever (ASF) continuing its spread through Eastern and Central Europe and industry leaders warning pig producers about an increased risk of ASF reaching the UK, specialty chemicals company LANXESS is recommending the implementation of strict biosecurity protocols to help prevent the spread of the disease.

Stephan Cho, Head of Market Segment Disinfection in the Material Protection Products business unit (MPP) at LANXESS, explains the importance of biosecurity best practice in combating the risk that African Swine Fever poses to the European swine production industry: “Prevention comes first,” says Cho. “Biosecurity is the only real way of stopping the spread of the African Swine Fever virus onto and around a swine production facility. Producers need to achieve the highest possible levels of biosecurity, leveraged by good buy-in and compliance from management, their staff and their suppliers.”

As part of their commitment to providing biosecurity advice and support, LANXESS has launched the Virkon 360° Biosecurity campaign, focusing on the key elements of biosecurity best practice for surfaces, equipment, air, and drinking water delivery systems, highlighting their proven and trusted Biosolve heavy-duty cleaners and Virkon disinfectant formulations.

Virkon S – proven effective against African Swine fever

LANXESS offers swine producers the proven broad spectrum virucidal disinfectant Virkon S for ASF biosecurity prevention and control measures. Having been independently tested [passus with reference to the name of the institute deleted on 21.09.2018] for virucidal efficacy against ASF, Virkon S is proven to be effective against the virus at a dilution rate of 1:800, in the presence of organic challenge and at low temperatures (down to 4 °C) reflecting its proven performance and suitability for real world “on farm” conditions. In addition, LANXESS is offering swine producers timely advice on the clinical symptoms of ASF and guidance on implementing enhanced biosecurity protocols across the range of possible infection vectors, including wild boar and other animals, transport vehicles, housing facilities and personnel.

“Virkon S is a scientific breakthrough with performance characteristics that have defined biosecurity standards for over 30 years, making it the disinfectant of choice for swine housing, surfaces, equipment, vehicles and footwear. It is especially effective in combating the spread of disease via transport vehicles,” adds Cho.

Read more about LANXESS and their commitment to biosecurity at

Forward-Looking Statements
This company release contains certain forward-looking statements, including assumptions, opinions, expectations and views of the company or cited from third party sources. Various known and unknown risks, uncertainties and other factors could cause the actual results, financial position, development or performance of LANXESS AG to differ materially from the estimations expressed or implied herein. LANXESS AG does not guarantee that the assumptions underlying such forward-looking statements are free from errors nor does it accept any responsibility for the future accuracy of the opinions expressed in this presentation or the actual occurrence of the forecast developments. No representation or warranty (expressed or implied) is made as to, and no reliance should be placed on, any information, estimates, targets and opinions, contained herein, and no liability whatsoever is accepted as to any errors, omissions or misstatements contained herein, and accordingly, no representative of LANXESS AG or any of its affiliated companies or any of such person's officers, directors or employees accept any liability whatsoever arising directly or indirectly from the use of this document.

LANXESS is a leading specialty chemicals company with sales of EUR 9.7 billion in 2017 and about 19,200 employees in 25 countries. The company is currently represented at 74 production sites worldwide. The core business of LANXESS is the development, manufacturing and marketing of chemical intermediates, additives, specialty chemicals and plastics. Through ARLANXEO, the joint venture with Saudi Aramco, LANXESS is also a leading supplier of synthetic rubber. LANXESS is listed in the leading sustainability indices Dow Jones Sustainability Index (DJSI World and Europe) and FTSE4Good.


Ilona Kawan

Ilona Kawan
Spokesperson Trade and Technical Press

Phone: +49 221 8885 1684

Fax: +49 221 8885 4865

send E-Mail